LoginGet started
Picture of Ramm Pharma logo

RAMM — Ramm Pharma Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Ramm Pharma, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

2019
October 31st
2020
October 31st
2021
October 31st
2022
October 31st
2023
October 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.82-7.43-7.11-21-7.72
Depreciation
Non-Cash Items4.544.291.5713.92.36
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital0.434-0.2390.9830.079-0.366
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Taxes Payable
Cash from Operating Activities-1.81-2.91-3.82-5.91-4.39
Capital Expenditures-0.388-1.89-0.43-0.168-0.062
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.1150.334-6.4-0.9840.189
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.273-1.56-6.83-1.150.127
Financing Cash Flow Items36.5-0.205-0.01——
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities36.4-2.91-0.19-0.354-0.41
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash34.5-7.36-10.9-7.38-4.66